COMING SOON The FDA Group's

Insider Newsletter

We're launching a subscription newsletter!

The FDA Group’s Insider Newsletter is a soon-to-be-launched premium newsletter that will deliver regulatory and compliance news, as well as highly-actionable analysis from former FDA staff and experienced life science consultants right to your inbox.

Subscribers will keep up on news and other happenings at the FDA seen through the lens of those who’ve worked within the FDA and the industries it oversees. New issues will arrive each month.

Sign up now to get an email notification to subscribe when we launch!

Notify me when subscriptions open »

Sign up to be notified via email when subscriptions open.

Submit your email address below to get an email notification when our newsletter officially launches and subscriptions open. Don't worry—we care as much about privacy as you do.

Get the latest life science news, analysis, and perspectives right in your inbox.

Each month, The FDA Group’s Insider Newsletter will deliver three pieces of regulatory and compliance news analyzed by former FDA staff and experienced life science consultants working in the FDA-regulated industries.

Each newsletter will contain a subscriber-only video of the expert contributor’s analysis with a transcript of the video and links to relevant articles and resources on the web. Subscribers will get actionable insights they won't find elsewhere.

Notify me when subscriptions open »

Why we're launching a newsletter—and why you'll find it valuable.

There are a handful of free and paid regulatory intelligence services that report on new regulations, FDA guidances, enforcement actions, etc.

Many of these services do a decent job of putting need-to-know industry news in front of you, but few—if any—actually provide the expert analysis and perspectives that help you understand what you need to do in light of, say, new a guidance being issued. Even fewer go so far to break down warning letters and pick out the key lessons from them.

It’s up to you to digest the information, determine the impact on your organization, and plan accordingly. That takes time and attention that we suspect you could better invest elsewhere.

Our newsletter will fill this gap.

Once a month, we'll be gathering regulatory and compliance happenings and put them to a former FDA official or experienced consultant with the appropriate background to analyze that news and distill it into actionable takeaways for RA, QA, and Clinical teams.

They'll record their analysis, and we'll send it to you. It's that simple.

We hope it will save you time hunting for that news and understanding what you need to do as a result of it—all through the lens of someone with deep industry or agency experience. We’ll cover new regulatory initiatives, dig into new guidances, pull out key themes of warning letters, and more.

Notify me when subscriptions open »

Watch a sample newsletter analysis.

HubSpot Video

Watch our "pilot" edition and get a sense of what to expect each month. We've gathered a team of former FDA professionals and industry consultants as our expert contributors.

Subscribers will get exclusive access to videos like this every month—covering topics across the pharma, device, and biologics industries.

Our pilot features contributor Larry Stevens, RAC, a life science consultant who has held almost every field position within FDA during his 21-year career with the agency.

How much will it cost?

The FDA Group's Insider Newsletter will cost $29.99/month.

Those who sign up to receive a launch notification will receive an exclusive discount.

What will it look like?

Each newsletter will contain:

  • A video containing the expert analysis of the three items we cover that month.
  • A transcript of the analysis if you prefer to read it, or take some of the analysis with you.
  • Any supplemental resources our contributors can make available such as slide decks and additional documentation.
  • A convenient list of links to related articles and content.

 

How will I subscribe?

The newsletter will be hosted and delivered via Substack, a platform designed specifically for independent newsletter publishers.

Payments will be handled securely through Substack, which uses Stripe as its checkout platform. 

At this time, Substack accepts most major credit cards such as Visa, MasterCard, Discover, and American Express.

Will I be able to cancel my subscription?

Yes, of course. Substack makes it very easy to cancel any paid subscription. Once you cancel your subscription, it will terminate at the end of the billing period and you will not be charged again.

What sorts of content can I expect to receive?

We plan to cover news and topics relevant to RA/QA/Clinical professionals working in FDA-regulated industries. That includes new regulatory initiatives from FDA and other regulatory bodies, guidance document analyses, enforcement action breakdowns, and more. We'll be focusing on the pharmaceutical, medical device, and biologic industries in particular. 

How will this be different from other industry intelligence services?

The Insider Newsletter will be unique in a few ways:

  • Format: The format of this newsletter will be a mix of video and text. Our contributors aren't writing articles; they're recording themselves providing live analysis—much like they would with a client they may be working with in the field. We know subscribers may want to document the insights given in these videos, so we're including a transcript with each of them, as well as links to supplementary materials.
  • Substance: Unlike other regulatory intelligence services, our roster of contributors aren't "freelance" experts. They're trusted consultants from our own network—people we call on to tackle challenging projects with our clients. We'll bring a whole new level of subject matter expertise than you might be used to if you subscribe to other services.
  • Focus: We won't be covering day-to-day product approval news you can find in hundreds of places. We're focusing only on RA/QA/Clinical topics that directly impact our audience. These insights will be useful at a very practical level.

When will this newsletter launch?

We will likely open subscriptions in April 2022.

What happens when I fill out the form on this page?

When you submit your email using the form at the bottom of this page, we'll send you an email with a link to subscribe to our newsletter once subscriptions open.

Why subscribe?

fda-Illustration-LaboratoryAnalytical-Small

 

Save time finding and acting on regulatory initiatives.

Regulatory affairs, quality assurance, and clinical operations teams need to stay on top of a fast-moving regulatory environment. Hunting for news and scouring databases steals valuable time that’s better spent elsewhere. The Insider Newsletter gathers important news so you don’t have to. Each month, we aggregate the latest relevant regulatory happenings and deliver expert analysis on key topics. Quickly scan regulatory updates from the FDA and stay for insights that help you take action on them.

Get deep, actionable takeaways on the regulatory and compliance news impacting you.

It’s easy to get overwhelmed by the constant stream of regulatory information within the FDA-regulated industries. Keeping track of it all is hard enough. Understanding and responding to it thoughtfully is even harder. Our former FDA contributors analyze regulatory developments so you can focus on what it means for your organization and take efficient, effective action.

Be The First To Know When We Go Live Sign up to be notified via email when subscriptions open.

Submit your email address below to get an email notification when our newsletter officially launches and subscriptions open. Don't worry—we care as much about privacy as you do.